The aim of our project is to exploit miRNAs as drugs or targets in innovative therapeutic strategies for CLL and MM based on biological driven hypothesis, novel in vitro and in vivo preclinical models and delivery nanotechnologies. We propose an experimental platform which includes all steps from target identification (Task 1-2), bioreagent development (Task 3), in vivo preclinical validation (Task 4) and translation to clinical setting for assessment of the safety profile (Task 5) and final development as investigational new drug for FIRST in HUMAN studies (Task 6).

Associazione Italiana per la Ricerca sul Cancro AIRC 5xmille 2011 - A research platform for miRNA-based treatment of multiple myeloma and chronic lymphocytic leukemia

NEGRINI, Massimo
2012

Abstract

The aim of our project is to exploit miRNAs as drugs or targets in innovative therapeutic strategies for CLL and MM based on biological driven hypothesis, novel in vitro and in vivo preclinical models and delivery nanotechnologies. We propose an experimental platform which includes all steps from target identification (Task 1-2), bioreagent development (Task 3), in vivo preclinical validation (Task 4) and translation to clinical setting for assessment of the safety profile (Task 5) and final development as investigational new drug for FIRST in HUMAN studies (Task 6).
2012
Negrini, Massimo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/1829724
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact